![]() |
Market Research Report
Product code
966631
Allergy Diagnostics Market, by Products and Services, By Test Types, By Allergan Type, By End User and By Geography - Analysis, Size, Share, Trends, & Forecast from 2021-2027 |
Allergy Diagnostics Market, by Products and Services, By Test Types, By Allergan Type, By End User and By Geography - Analysis, Size, Share, Trends, & Forecast from 2021-2027 |
Published: October 1, 2020
AnalystView Market Insights
Content info: 213 Pages
Delivery time: 2-3 business days
|
Title:
Allergy Diagnostics Market, by Products and Services (Consumables, Instruments and Services), By Test Types (Invivo Test and Invitro Tests), By Allergan Type (Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens), By End User (Diagnostics Laboratories, Hospital-based Laboratories, Academic and Research Institutes) and By Geography (EU, NA, APAC, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2021-2027.
The global Allergy Diagnostics market was valued at USD 4.42 billion by 2019, growing with 11.6% CAGR during the forecast period, 2021-2027.
An allergy is an immune system reaction to an extraneous element that's not characteristically harmful to the body. These extraneous or foreign substances are termed as allergens. They can comprise certain pollen, pet dander, or foods. Patients exhibit frequently an extensive range of variable symptoms and sensitization patterns contrary to numerous allergens. It is crucial to diagnose a patient's blood each and every time response or severe reaction is assumed. The allergy diagnostics deliver quantifiable test procedures for the detection of antibodies, the enzyme immunoblot, and immunoassay.
Market Dynamics
Increasing demand for in vitro diagnostic blood tests combined with snowballing incidences of allergic diseases is predictable to foster the industry growth in the upcoming years.
According to the assessments published by the Healthline, there are estimations that more than 60 million people in the United States possess symptoms of allergic rhinitis and the figure is growing subsidizing towards the market growth. Similarly, factors, such as rising levels of outdoor and indoor pollution, shifting lifestyles, rapid urbanization, and poor dietary habits across the world, are projected to result in an augmented prevalence of allergic conditions. This, sequentially, is anticipated to help supplement the industry growth over the analysis period. The launch of scientifically advanced diagnostic procedures that deliver incredibly accurate and sensitive results is also likely to have an optimistic impact on the overall market growth in the coming years. Nevertheless, the dearth of standardization in allergen testing practices is expected to hinder the market growth.
Product and Services Takeaway
Depending on Product and Services, the global business is categorized into consumables, instruments, and services. The consumables category occupied the lion's share in 2019 and anticipated remarkable growth during the analysis period. The growth of this category is primarily accredited to the growth in food security concerns. Similarly, the mounting research and development in the life sciences and pharmaceutical industry upsurge the demand for analytical instruments and boosts market growth.
There is a high number of small and medium-sized manufacturers such as Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Qiagen N.V., and Rad Laboratories, Inc., concerned with devising and delivering various instruments used in the investigation of diseases caused by allergy to present comprehensive and better patient care providing speed, ease of use and accurate analytical instruments. For example, various technological advancements include allergen microarray kits that are semi-quantitative multiplex protein arrays technologically advanced for the recognition of antibodies to the most common allergens.
Other developments that are more profound and deliver individualized patient monitoring and profiling are estimated to foster this segment's market growth. The introduction of novel products, such as MeDALL allergen-chip combined with greater specificity, sensitivity, and rapid diagnosis is likely to supplement the market growth expansion.
Test Types Takeaway
In terms of test types, the worldwide industry is categorized into the in-vivo and in-vitro tests. In vitro test is likely to witness noteworthy progression in the upcoming years due to the growing demand for lab automation, less invasive diagnostic methods, and extremely accurate and sensitive results. Manufacturers are also concentrating on providing accurate result-oriented devices and allergy-specific solutions to achieve a significant market share.
In vivo tests accounted for more than half of the overall market share due to the concomitant benefits, such as broader availability, time efficiency, sensitivity for clinically valid allergies, and ease of use. Moreover, skin prick tests held a substantial share in 2019 due to more massive patient and healthcare professionals' adoption. This is primarily due to the increasing applicability of these tests in detecting food allergy; specific IgE intervened testing.
Allergan Type Takeaway
By Allergan type, the market is classified into an inhaled allergens, food allergens, drug allergens, and other allergens. Inhaled allergen dominated the market in 2019 due to amplified asthma and other respiratory tract allergies across the world. The segment is predicted to develop in the forecast period at the fastest growth rate due to the extraordinary demand for testing allergies and the launch of definite allergen for the recognition of allergy.
Food allergies are expected to grow with a remarkable CAGR during the prediction period. Kids and youngsters are more vulnerable to these sorts of diseases caused by an allergy. According to the estimations proclaimed by the United States National Institute of Health (U.S.NIH), the incidence of allergies related to food among children is twofold that of elders.
End-user Takeaway
In terms of end-user, the worldwide industry is categorized into diagnostics laboratories, hospital-based laboratories, academic and research institutes, and others. The diagnostic laboratories segment held the largest share and is forecasted to retain its supremacy throughout the forecast period, due to its wide deployment of immunoassay tests.
Regional Takeaway
Regionally, the overall industry is divided into North America, Middle East & Africa, Asia Pacific, Latin America, and Europe. North America held the lion's share in 2019 because of an extraordinary prevalence of respiratory allergic disorders accompanied by the increasing awareness levels regarding the allergy diagnostics and the implementation of tests including in vitro blood tests.
APAC is projected to witness the fastest growth owing to the unmet medical needs, speedily extemporizing healthcare infrastructure, and the need for minimally invasive diagnostic tools. Europe is anticipated to be the second-largest market due to the growing demand for therapeutics and the advanced pharmaceutical industry. The increasing incidences of allergic conditions and the growing geriatric population also subsidize the growth in this region.
COVID-19 Impact
The growth of the COVID-19 pandemic brought the world together to a standstill. Nevertheless, the market for allergen diagnostics has seen a surge across the world. According to the analysis from World Health Organization, the market progressed between December 2019 to April 2020, and it also revealed that developmental collaborations, product commercialization, and product distribution partnerships were adopted by the various industry players to retain an economic position in the allergy diagnostics market to alleviate the COVID-19 impact. Product commercialization was the most extensively adopted growth strategy.
Key Vendor Takeaway
Siemens AG, Danaher Corporation, Thermo Fisher Scientific Inc., Hitachi Chemical Co., Ltd., BioMerieux SA, Omega Diagnostics Group PLC, Stallergenes Greer, HOB Biotech Group Suzhou Co. Ltd., HYCOR Biomedical, and Lincoln Diagnostics, Inc., among others.
The principal players are actively adopting various strategies such as acquisition, geographical expansion, development of new and efficient therapeutics, etc. to maintain their position in the market. The companies are also involved in the strategic development of new products, such as in March 2019, Neogen launched Reveal 3-D for Coconut Allergen screens environmental and liquid samples at 1 part per million (ppm) in only 5 minutes.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2016 to 2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2021 to 2027
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ALLERGY DIAGNOSTICS MARKET KEY PLAYERS
Siemens AG
Thermo Fisher Scientific Inc.
Danaher Corporation
Omega Diagnostics Group PLC
Hitachi Chemical Co., Ltd.
BioMerieux SA,
Stallergenes Greer
HOB Biotech Group Suzhou Co., Ltd.
HYCOR Biomedical
Lincoln Diagnostics, Inc.
GLOBAL ALLERGY DIAGNOSTICS MARKET BY PRODUCTS AND SERVICES
Consumables
Instruments
Luminometers
ELISA Analyzers
Other Instruments
Services
GLOBAL ALLERGY DIAGNOSTICS MARKET BY TEST TYPES
In Vivo Tests
In Vitro Tests
GLOBAL ALLERGY DIAGNOSTICS MARKET BY ALLERGAN TYPE
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens
GLOBAL ALLERGY DIAGNOSTICS MARKET BY END-USER
Diagnostics Laboratories
Hospital-based Laboratories
Academic and Research Institutes
Other End Users
GLOBAL ALLERGY DIAGNOSTICS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Singapore
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of MEA